Status:

COMPLETED

The Relationship Between Systemic Immune Inflammation Index and Disease Activity in Patients With Ankylosing Spondylitis

Lead Sponsor:

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

Conditions:

Ankylosing Spondylitis

Eligibility:

All Genders

18-65 years

Brief Summary

In this study, the aim was to investigate the relationship between SII and other laboratory parameters with disease activity in AS patients and to discuss its usability in the follow-up and treatment ...

Detailed Description

This study aimed to investigate the relationship between the systemic immune inflammation index (SII), platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), and disease activity an...

Eligibility Criteria

Inclusion

  • Patients between the ages of 18 and 65 who have been diagnosed with Ankylosing Spondylitis according to the Modified New York Criteria, have applied to the Istanbul Physical Medicine and Rehabilitation Training and Research Hospital outpatient clinic on the specified dates, meet the exclusion criteria, and have complete blood count, CRP, and ESR values in their hospital records.

Exclusion

  • Presence of acute or chronic infection
  • Presence of autoimmune diseases other than Ankylosing Spondylitis
  • Pregnancy
  • Diabetes
  • Chronic kidney disease
  • Chronic liver disease
  • Malignancy
  • Cardiovascular disease
  • Hematological disease

Key Trial Info

Start Date :

June 1 2023

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 2 2023

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT06094673

Start Date

June 1 2023

End Date

July 2 2023

Last Update

February 20 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Istanbul Physical Therapy and Rehabilitation Research and Training Hospital

Istanbul, Bahcelievler, Turkey (Türkiye), 34147